Short Original
Tocilizumab in the treatment of active chronic humoral rejection resistant to standard therapy
Tocilizumab en el tratamiento del rechazo humoral crónico activo resistente a terapia estándar
Betty Chamouna,
, Pablo Sánchez-Sanchob, Irina B. Torresa,
, Alejandra Gabaldonc, Manel Perellóa, Joana Sellarésa, Francesc Moresoa, Daniel Seróna
Corresponding author
Corresponding author
a Servicio de Nefrología, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
b Servicio de Farmacia, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
c Servicio de Patología, Hospital Universitari Vall d’Hebron, Universidad Autónoma de Barcelona, Barcelona, Spain
Read
3595
Timeswas read the article
1419
Total PDF
2176
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 34 | 53 | 87 |
| 2025 5 | 152 | 42 | 194 |
| 2025 4 | 91 | 26 | 117 |
| 2025 3 | 140 | 64 | 204 |
| 2025 2 | 118 | 47 | 165 |
| 2025 1 | 81 | 48 | 129 |
| 2024 12 | 74 | 43 | 117 |
| 2024 11 | 70 | 56 | 126 |
| 2024 10 | 73 | 45 | 118 |
| 2024 9 | 71 | 36 | 107 |
| 2024 8 | 79 | 78 | 157 |
| 2024 7 | 68 | 32 | 100 |
| 2024 6 | 70 | 47 | 117 |
| 2024 5 | 58 | 44 | 102 |
| 2024 4 | 77 | 43 | 120 |
| 2024 3 | 56 | 33 | 89 |
| 2024 2 | 45 | 43 | 88 |
| 2024 1 | 61 | 31 | 92 |
| 2023 12 | 46 | 35 | 81 |
| 2023 11 | 68 | 34 | 102 |
| 2023 10 | 73 | 54 | 127 |
| 2023 9 | 53 | 37 | 90 |
| 2023 8 | 82 | 42 | 124 |
| 2023 7 | 77 | 68 | 145 |
| 2023 6 | 92 | 81 | 173 |
| 2023 5 | 86 | 72 | 158 |
| 2023 4 | 54 | 60 | 114 |
| 2023 3 | 70 | 56 | 126 |
| 2023 2 | 54 | 66 | 120 |
| 2023 1 | 3 | 3 | 6 |
Show all
